baricitinib, an oral janus kinase inhibitor, in the treatment of rheumatoid arthritis...
Published 11 years ago • 3.6K plays • Length 18:39Download video MP4
Download video MP3
Similar videos
-
5:23
tofacitinib, an oral janus kinase inhibitor
-
3:07
jak (janus kinase pathway) inhibitor tofacitinib - pharmacology, mechanism of action, side effects
-
26:03
jak inhibitors in rheumatoid arthritis
-
2:30
baricitinib had improved patient-reported outcomes in the treatment of rheumatoid arthritis
-
5:07
when to use a jak inhibitor in ra: dr. janet pope
-
36:51
the expanding role of jak inhibitors across imids
-
4:08
infections in baricitinib clinical trials for patients with active rheumatoid arthritis
-
5:45
tofacitinib | jak (janus kinase pathway) inhibitor tofacitinib - pharmacology, mechanism of action.
-
7:09
baricitinib in patients with inadequate response or intolerance to conventional synthetic dmards
-
6:20
jak inhibitor treatment shows benefit for patients with interferonopathies
-
30:02
safety of baricitinib 4 mg for the treatment of rheumatoid arthritis
-
0:28
jak inhibitors: baricitinib for atopic dermatitis and alopecia areata
-
15:32
the role of jak inhibitors in your clinical practice
-
34:32
axial spondyloarthritis treatment advancements: where do janus kinase inhibitors fit in?
-
43:42
jak-inhibition in immune-mediated diseases (imids)
-
5:06
jak inhibitors in rheumatic diseases
-
9:11
discussing rheumatology: march 2023
-
2:09
jak kinase inhibitors
-
7:59
discussing rheumatology: jak inhibitor monotherapy in ra